Holen Sie sich die Stockscreener-App
1.73
0.00%
0.00
Handel nachbörslich:
1.71
-0.02
-1.16%
Schlusskurs vom Vortag:
$1.73
Offen:
$1.7201
24-Stunden-Volumen:
44,006
Relative Volume:
0.34
Marktkapitalisierung:
$82.04M
Einnahmen:
$9.16M
Nettoeinkommen (Verlust:
$-68.17M
KGV:
-1.0176
EPS:
-1.7
Netto-Cashflow:
$-80.16M
1W Leistung:
+2.37%
1M Leistung:
+1.17%
6M Leistung:
+21.83%
1J Leistung:
-60.05%
1-Tages-Spanne:
$1.69
$1.755
1-Wochen-Bereich:
$1.67
$1.755
52-Wochen-Spanne:
$1.02
$4.625
Ikena Oncology Inc Stock (IKNA) Company Profile
Firmenname
Ikena Oncology Inc
Sektor
Branche
Telefon
857-343-8292
Adresse
50 NORTHERN AVE., BOSTON
Ikena Oncology Inc Stock (IKNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-05-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2021-12-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-05-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-26 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-04-20 | Eingeleitet | Credit Suisse | Outperform |
| 2021-04-20 | Eingeleitet | Jefferies | Buy |
| 2021-04-20 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Ikena Oncology Inc Aktie (IKNA) Neueste Nachrichten
Acadian Asset Management LLC Has $536,000 Stake in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Analyzing Ikena Oncology (NASDAQ:IKNA) & Kiromic BioPharma (NASDAQ:KRBP) - Defense World
Ikena Oncology, Inc. (NASDAQ:IKNA) Sees Large Drop in Short Interest - MarketBeat
Ikena Oncology, Inc. (NASDAQ:IKNA) Short Interest Down 10.7% in July - Defense World
Ikena Oncology, Inc. (NASDAQ:IKNA) Short Interest Down 10.7% in July - MarketBeat
Q3 2024 EPS Estimates for Ikena Oncology, Inc. (NASDAQ:IKNA) Lifted by HC Wainwright - MarketBeat
Ikena Oncology, Inc. (NASDAQ:IKNA) Expected to Post Q3 2024 Earnings of ($0.26) Per Share - Defense World
HC Wainwright Reaffirms "Buy" Rating for Ikena Oncology (NASDAQ:IKNA) - MarketBeat
Ikena Oncology (NASDAQ:IKNA) Receives Buy Rating from HC Wainwright - Defense World
Ikena Oncology (NASDAQ:IKNA) Announces Quarterly Earnings Results, Beats Estimates By $0.04 EPS - Defense World
Ikena Oncology Reports Second Quarter 2024 Financial Results - GlobeNewswire
Ikena Oncology Reports Second Quarter 2024 Financial Results - Yahoo Finance
Jacobs Levy Equity Management Inc. Increases Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Jacobs Levy Equity Management Inc. Boosts Holdings in Ikena Oncology, Inc. (NASDAQ:IKNA) - MarketBeat
Acadian Asset Management LLC Raises Position in Ikena Oncology, Inc. (NASDAQ:IKNA) - Defense World
Ikena Oncology, Inc. (NASDAQ:IKNA) Sees Significant Decline in Short Interest - MarketBeat
Ikena Oncology to Present Preclinical Findings on IK-930, a Novel TEAD Inhibitor at the 2022 American Association for Cancer Research (AACR) Annual Meeting - Barchart
Ikena Oncology, Inc. (NASDAQ:IKNA) Sees Significant Drop in Short Interest - Defense World
Ikena Oncology expands role of CFO Jotin Marango to COO - Investing.com
Ikena Oncology expands role of CFO Jotin Marango to COO - Investing.com India
Ikena Oncology Promotes Jotin Marango to Chief Operating Officer - TipRanks
New Strong Buy Stocks for July 12th - Yahoo Finance
Best Momentum Stocks to Buy for July 12th - Yahoo Finance
Down -29.05% in 4 Weeks, Here's Why Ikena Oncology, Inc. (IKNA) Looks Ripe for a Turnaround - MSN
Take off with Ikena Oncology Inc (IKNA): Get ready for trading – Sete News - SETE News
Short Interest in Ikena Oncology, Inc. (NASDAQ:IKNA) Decreases By 9.0% - MarketBeat
Fierce Biotech Layoff Tracker 2024: Takeda axes another 220 jobs; Ovid undergoes 43% reduction - Fierce Biotech
Ikena Oncology - The Pharma Letter
HC Wainwright & Co. Reiterates Ikena Oncology (IKNA) Buy Recommendation - MSN
Why Ikena Oncology (IKNA) Might Surprise This Earnings Season - Yahoo News Malaysia
Head and Neck cancer Pipeline Forecast 2024: FDA Approvals, - openPR
Ikena Oncology Reports First Quarter 2022 Financial Results and Provides a Corporate Update - Quantisnow
Ikena Oncology Announces $40 Million Underwritten Offering - Quantisnow
Ikena Oncology to Participate in Cowen 42nd Annual Health Care Conference - Quantisnow
Ikena Oncology to Participate in the William Blair Biotech Focus Conference 2022 - Quantisnow
Seismic Therapeutic Appoints Maude Tessier, PhD, as Chief Business Officer - Quantisnow
Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference - Quantisnow
Ikena Oncology (NASDAQ:IKNA shareholders incur further losses as stock declines 16% this week, taking one-year ... - Yahoo Movies UK
Examining Ikena Oncology Inc (IKNA) stock is warranted – US Post News - US Post News
Ikena Oncology, Inc.'s (NASDAQ:IKNA) largest shareholders are private equity firms with 46% ownership, institutions ... - Yahoo Canada Sports
Ikena Oncology, Inc. (NASDAQ:IKNA) Sees Significant Growth in Short Interest - MarketBeat
Ikena Oncology, Inc. (NASDAQ:IKNA) Shares Bought by BVF Inc. IL - Defense World
Ikena Oncology, Inc. (NASDAQ:IKNA) Stock Position Lifted by BVF Inc. IL - MarketBeat
Ikena Oncology, Inc. (IKNA) Stock Jumps 7.9%: Will It Continue to Soar? - Yahoo Movies Canada
Ikena Oncology (NASDAQ:IKNA) vs. Biogen (NASDAQ:BIIB) Head-To-Head Review - Defense World
Comparing Ikena Oncology (NASDAQ:IKNA) & Quince Therapeutics (NASDAQ:QNCX) - Defense World
Ikena Oncology, Inc. (IKNA) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Movies UK
Reviewing Ikena Oncology (NASDAQ:IKNA) & Dyadic International (NASDAQ:DYAI) - Defense World
Q2 2024 EPS Estimates for Ikena Oncology, Inc. Reduced by Analyst (NASDAQ:IKNA) - MarketBeat
Ikena Oncology, Inc. (NASDAQ:IKNA) Short Interest Down 9.2% in May - MarketBeat
Ikena Oncology, Inc. (NASDAQ:IKNA) to Post Q2 2024 Earnings of ($0.27) Per Share, William Blair Forecasts - Defense World
Finanzdaten der Ikena Oncology Inc-Aktie (IKNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
4.86%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):